• Radiopathomics and Machine Learning Predict Immunotherapy Re

  2026-04-28

  This study introduces a multimodal radiopathomics signature (RPS) integrating computed tomography and digital pathology with interpretable machine learning to predict response to immunotherapy-based combination therapy in gastric cancer. The RPS outperforms conventional biomarkers, providing a robust prognostic tool and insight into immune microenvironment features.

• Shionone Activates Mitophagy via PINK1-Parkin to Combat Pulm

  2026-04-28

  This study reveals that Shionone, a terpenoid from Ligularia fischeri, alleviates pulmonary fibrosis by activating mitophagy through the PINK1-Parkin pathway. The work provides a mechanistic basis for Shionone's anti-fibrotic effects and highlights the importance of mitochondrial quality control and oxidative stress assays in pulmonary fibrosis research.

• Stattic as a STAT3 Inhibitor: Precision Tools for Cancer Pat

  2026-04-27

  Explore Stattic, a potent STAT3 inhibitor, and its role in dissecting cancer biology—especially in apoptosis induction and radiosensitization. This article uniquely bridges mechanistic insights with practical assay guidance, grounded in recent translational research.

• AMPA/NMDA Receptor Blockade Mitigates Soman-Induced Neurotox

  2026-04-27

  This study demonstrates that the dual AMPA/NMDA receptor antagonist IEM-1925 offers superior antiseizure, neuroprotective, and cognitive benefits in a rat model of soman-induced status epilepticus. The findings point to glutamate receptor blockade as a promising strategy for addressing organophosphorus nerve agent neurotoxicity.

• NF 340: Precision P2Y11 Antagonist for GPCR Signaling Resear

  2026-04-26

  NF 340 from APExBIO empowers researchers to dissect P2Y11-driven signaling events with unmatched selectivity and reproducibility. Its application in breast cancer invasiveness assays and inflammation pathway modulation highlights its role as a cornerstone tool for advanced immunology and cancer biology research.

• AMPK's Dual Role in Autophagy: Revisiting the ULK1-Vps34 Axi

  2026-04-25

  This study overturns the prevailing model of energy stress response, revealing that AMPK inhibits, rather than activates, autophagy initiation via ULK1 suppression during glucose starvation. These findings reshape our understanding of metabolic regulation of autophagy and highlight new considerations for experimental design using Vps34 inhibitors.

• Alfuzosin HCl: Strategic Guidance for Translational BPH Rese

  2026-04-24

  This thought-leadership article integrates mechanistic insights, experimental best practices, and translational strategies for researchers leveraging Alfuzosin HCl in benign prostatic hyperplasia (BPH) studies. Drawing on recent advances in gastroretentive delivery, pharmacokinetics, and assay development, it positions APExBIO’s Alfuzosin Hydrochloride (SKU A5173) as a benchmark α1 adrenoceptor antagonist for next-generation urinary research.

• Icatibant in Viral Infections: Insights for Translational Re

  2026-04-24

  Mustonen et al. (2023) synthesize case evidence and recent trial data on the use of icatibant, a bradykinin B2 receptor antagonist, in severe viral infections characterized by vascular permeability and organ involvement, including acute Puumala hantavirus and COVID-19 pneumonia. Their analysis highlights the translational rationale for targeting the kinin-kallikrein system (KKS) and the need for early intervention, offering a nuanced perspective for future therapeutic research.

• CA-074 Me: Precision Cathepsin B Inhibitor for Lysosomal Stu

  2026-04-23

  CA-074 Me delivers unmatched selectivity and cell permeability for dissecting cathepsin B-driven cell death and inflammation pathways. This article guides researchers through optimized workflows, troubleshooting, and novel applications, leveraging the latest mechanistic advances in lysosomal membrane permeabilization and necroptosis.

• miR-122-5p Regulates PKM2 in Metabolic Syndrome: Mechanistic

  2026-04-23

  This study elucidates the mechanistic link between miR-122-5p and metabolic syndrome by demonstrating that miR-122-5p negatively regulates PKM2, affecting insulin resistance and glucose metabolism in hepatic cells. The findings establish miR-122-5p as both a predictive biomarker and molecular mediator in the pathogenesis of metabolic syndrome, with implications for targeted biomarker analysis and gene expression workflows.

• Trelagliptin Enhances Osteoblast Differentiation via RUNX2 U

  2026-04-22

  This study demonstrates that Trelagliptin, beyond its antidiabetic role, stimulates osteoblastic differentiation by increasing RUNX2 expression through AMPK signaling. The findings suggest potential therapeutic implications for osteoporosis management, offering new insight into bone metabolic modulation.

• SD 169 (Indole-5-Carboxamide): Translational Leaps in p38 MA

  2026-04-22

  This thought-leadership article dissects the mechanistic breakthroughs enabled by SD 169 (indole-5-carboxamide), a selective ATP-competitive p38α/β MAPK inhibitor. Bridging recent evidence on kinase dephosphorylation with strategic recommendations, it provides translational researchers actionable insights for designing experiments in diabetes, neuroregeneration, and inflammation. Unlike conventional overviews, this piece critically evaluates dual-action inhibition, contextualizes the evolving competitive landscape, and guides users in leveraging SD 169’s unique features to maximize research impact.

• Prochlorperazine: Applied Workflows in Melanoma and Antiemet

  2026-04-21

  Prochlorperazine stands out as a versatile dopamine D2 receptor antagonist with proven utility in melanoma research, antiviral studies, and antiemetic therapy. This article delivers actionable protocols, troubleshooting insights, and data-driven performance benchmarks for optimizing experimental outcomes with APExBIO’s Prochlorperazine.

• Structure-Based Screening Identifies NSP15 Inhibitors in SAR

  2026-04-21

  This article reviews a 2021 study that used structure-based virtual screening to identify thymopentin and oleuropein as potent inhibitors of the SARS-CoV-2 NSP15 endoribonuclease. The work elucidates a promising strategy for targeting viral immune evasion mechanisms, with implications for future antiviral drug development.

• Amiloride (MK-870): Advanced Insights for Ion Channel and En

  2026-04-20

  Explore how Amiloride (MK-870) enables nuanced dissection of sodium channel and endocytosis pathways. This article delivers a deep analysis of its mechanistic roles, unique assay considerations, and new evidence from virology that broadens its research utility.

451 records 20/31 page Previous Next First page 上5页 1617181920 下5页 Last page